Martin Sebastin Santhosh

Martin Sebastin Santhosh

Auto-generated profile, based on publicly available information

Martin Sebastin Santhosh

Department of Studies in Biochemistry University of Mysore Mysore India

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2011 in Basic & Clinical Pharmacology & Toxicology
Verified
Journal Article
Closed access
PDF file
MHMahadevappa Hemshekhar
Mahadevappa Hemshekhar
MSMartin Sebastin Santhosh
Martin Sebastin Santhosh
KKKempaiah Kemparaju
Kempaiah Kemparaju
KGKesturu S. Girish
Kesturu S. Girish

25 February 2011 in Phytochemistry Reviews
Verified
Journal Article
Closed access
PDF file
MHM. Hemshekhar
M. Hemshekhar
KSK. Sunitha
K. Sunitha
MSM. Sebastin Santhosh
M. Sebastin Santhosh
SDS. Devaraja
S. Devaraja
KKK. Kemparaju
K. Kemparaju
KGK. S. Girish
K. S. Girish

11 March 2013 in Free Radical Research
Verified
Journal Article
Closed access
KSK. Sunitha
K. Sunitha
MHM. Hemshekhar
M. Hemshekhar
RTR. M. Thushara
R. M. Thushara
MSM. Sebastin Santhosh
M. Sebastin Santhosh
MYM. Yariswamy
M. Yariswamy
KGKesturu S Girish
Kesturu S Girish
In the present human health scenario, implication of oxidative stress in numerous pathologies including neurodegenerative, cardiovascular, liver, renal, pulmonary disorders, and cancer has gained attention. N-Acetylcysteine (NAC), a popular thiol antioxidant, has been clinically used to treat various pathophysiological disorders. However, NAC therapy is routine only in paracetamol intoxication and as a mucolytic agent. Over six decades, numerous studies involving NAC therapy have yielded inconsistent results, and this could be due to low bioavailability. In order to overcome the limitations of NAC, an amide derivative N-Acetylcysteine amide (NACA) has been synthesized to improve the lipophilicity, membrane permeability, and antioxidant property. Recent studies have demonstrated the blood–brain barrier permeability and therapeutic potentials of NACA in neurological disorders including Parkinson's disease, Alzheimer's disease, Multiple sclerosis, Tardive dyskinesia, and HIV-associated neurological disorders. In addition, NACA displays protective effect against pulmonary inflammation and antibiotic-induced apoptosis. Forthcoming research on the possible therapeutic properties of NACA and its generics in the management of pathologies associated with extracellular matrix degradation and oxidative stress-related inflammation is highly exiting. Superior bioavailability of NACA is likely to fulfill the promises of NAC as well as a molecule to improve the endurance and resident time of bioscaffolds and biomaterials. Till date, more than 800 reviews on NAC have been published. However, no comprehensive review is available on the therapeutic applications of NACA. Therefore, the current review would be the first to emphasize the therapeutic potentials of NACA and its derivatives.

1 December 2012 in Biochimie
Verified
Journal Article
Closed access
MHM. Hemshekhar
M. Hemshekhar
MSM. Sebastin Santhosh
M. Sebastin Santhosh
KSK. Sunitha
K. Sunitha
RTR.M. Thushara
R.M. Thushara
KKK. Kemparaju
K. Kemparaju
KGK.S. Girish
K.S. Girish

15 August 2012 in Cell Biochemistry and Function
Verified
Journal Article
Closed access
PDF file
MSM. Sebastin Santhosh
M. Sebastin Santhosh
MHM. Hemshekhar
M. Hemshekhar
RTR. M. Thushara
R. M. Thushara
SDS. Devaraja
S. Devaraja
KKK. Kemparaju
K. Kemparaju
KGK. S. Girish
K. S. Girish

5 March 2014 in Journal of Pineal Research
Verified
Journal Article
Closed access
PDF file
GKG. D. Katkar
G. D. Katkar
Shanmuga S MahalingamShanmuga S Mahalingam
Shanmuga S Mahalingam
MHM. Hemshekhar
M. Hemshekhar
DSD. Rachana Sharma
D. Rachana Sharma
MSM. Sebastin Santhosh
M. Sebastin Santhosh
KKKempaiah Kemparaju
Kempaiah Kemparaju